Casa Sollievo della Sofferenza
San Giovanni Rotondo 71013
2 studies enrolling now · 9 studies all time
What they study most
Chemotherapy-induced Peripheral Neuropathy, Colitis, Ulcerative, Colorectal Cancer, Crohn's Disease, Fistulizing Crohns Disease, Heart Failure, Huntington Disease, Metastatic Breast Cancer, Multiple Myeloma, Perianal Crohns Disease
Studies at this site
- Pridopidine Phase 3 Study in Huntington's Disease — Recruiting now
- Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation — Recruiting now
- A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
- A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease — Running, not enrolling
- A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
- SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer — Completed
- MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing — Stopped early
- Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M) — Stopped early